Phathom Pharmaceuticals Files 8-K
Ticker: PHAT · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1783183
| Field | Detail |
|---|---|
| Company | Phathom Pharmaceuticals, Inc. (PHAT) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, disclosure
TL;DR
Phathom Pharma filed an 8-K, but details are scarce.
AI Summary
Phathom Pharmaceuticals, Inc. filed an 8-K on June 16, 2025, reporting an "Other Event." The filing does not contain specific details about the event, dollar amounts, or dates beyond the filing date itself.
Why It Matters
This filing indicates a material event has occurred for Phathom Pharmaceuticals, requiring disclosure to investors, though the specifics are not yet detailed.
Risk Assessment
Risk Level: medium — The filing is an 8-K, which typically reports material events, but the lack of specific details in this filing creates uncertainty.
Key Players & Entities
- Phathom Pharmaceuticals, Inc. (company) — Registrant
- June 16, 2025 (date) — Filing Date
FAQ
What specific event is Phathom Pharmaceuticals reporting in this 8-K filing?
The filing is an 8-K reporting an 'Other Event' but does not provide specific details about the nature of the event.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on June 16, 2025.
What is the principal executive office address for Phathom Pharmaceuticals?
The principal executive offices are located at 100 Campus Drive, Suite 102, Florham Park, New Jersey 07932.
What is the telephone number for Phathom Pharmaceuticals?
The telephone number is (877) 742-8466.
What is the SIC code for Phathom Pharmaceuticals?
The Standard Industrial Classification (SIC) code is 2834 for Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding Phathom Pharmaceuticals, Inc. (PHAT).